Molecular susceptibility to glycation and its implication in diabetes mellitus and related diseases

Molecular and Cellular Biochemistry

Volumn 344, Issue 1-2, 2010, Pages 185-193

  Méndez, José D ^c   Xie, Jianling ^a   Aguilar Hernández, Montserrat ^a   Méndez Valenzuela, Verna ^b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c NONE

Author keywords

Advanced glycation end products; Chronic complications; Diabetes mellitus; Hyperglycemia; Lipids; Nucleic acids; Proteins

Indexed keywords

ADVANCED GLYCATION END PRODUCT; COLLAGEN; HEMOGLOBIN; LIPOPROTEIN; NUCLEIC ACID; PHOSPHATIDYLETHANOLAMINE; PROTEIN KINASE C;

ARTICLE; ATHEROSCLEROSIS; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; GLYCATION; HEART DISEASE; HUMAN; LIPID METABOLISM; NONHUMAN; PATHOGENESIS; PERIPHERAL VASCULAR DISEASE; PROTEIN METABOLISM; STROKE;

DIABETES COMPLICATIONS; DIABETES MELLITUS; GLUCOSE; HUMANS;

EID: 78449295428     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-010-0541-3     Document Type: Article

References (79)

1. PJ Thornalley A Langborg HS Minhas 1999 Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose Biochem J 344 109 116 1:CAS:528:DyaK1MXns1yjtrY%3D 10.1042/0264-6021:3440109 10548540
2. R Signh A Barden T Mori L Beilin 2001 Advanced glycation end-products: a review Diabetologia 44 129 146 10.1007/s001250051591
3. KJ Knecht MS Feather JW Baynes 1992 Detection of 3-deoxyfructose and 3-deoxyglucosone in human urine and plasma: evidence for intermediate stages of the Maillard reaction in vivo Arch Biochem Biophys 294 130 137 1:CAS:528:DyaK38XhvFSmtbo%3D 10.1016/0003-9861(92)90146-N 1550339
4. O Chappey C Dosquet MP Wautier JL Wautier 1997 Advanced glycation end products, oxidant stress and vascular lesions Eur J Clin Invest 27 97 108 1:CAS:528:DyaK2sXhvVShtL0%3D 10.1046/j.1365-2362.1997.710624.x 9061302
5. DV Zyzak JM Richardson SR Thorpe JW Baynes 1995 Formation of reactive intermediates from Amadori compounds under physiological conditions Arch Biochem Biophys 316 547 554 1:CAS:528:DyaK2MXjsV2htL4%3D 10.1006/abbi.1995.1073 7840665
6. VM Monnier A Cerami 1981 Nonenzymatic browning in vivo: possible process for aging of long-lived proteins Science 211 491 493 1:CAS:528: DyaL3MXotFWgtQ%3D%3D 10.1126/science.6779377 6779377
7. D Sell I Namet VM Monnier 2010 Partial characterization of the molecular nature of collagen-linked fluorescence: role of diabetes and end-stage renal disease Arch Biochem Biophys 493 192 206 1:CAS:528:DC%2BC3cXoslSl 10.1016/j.abb.2009.10.013 19879855
8. HG Kunkel G Wallenius 1955 New hemoglobins in normal adult blood Science 122 228 229 10.1126/science.122.3163.288
9. G Fermi MF Perutz B Shaanan R Fourme 1984 The crystal structure of human deoxyhemoglobin at 1.74 Å J Mol Biol 175 159 174 1:CAS:528: DyaL2cXktF2gsbk%3D 10.1016/0022-2836(84)90472-8 6726807
10. DW Allen WA Schroeder J Balog 1958 Observations on the chromatographic heterogeneity of normal adult and fetal human hemoglobin J Am Chem Soc 80 1628 1634 1:CAS:528:DyaG1cXlslajtw%3D%3D 10.1021/ja01540a030
11. SH Chiou LT Chylack Jr WH Tung HF Bunn 1981 Nonenzymatic glycosylation of bovine lens crystallins J Biol Chem 256 5176 5180 1:CAS:528:DyaL3MXktVChurg%3D 7228874
12. R Shapiro MJ McManus C Zalur HF Bunn 1980 Sites of nonenzymatic glycosylation of human hemoglobin A J Biol Chem 255 3120 3127 1:CAS:528:DyaL3cXhvFejt7s%3D 7358733
13. M Brownlee 1995 Advanced protein glycosylation in diabetes and aging Annu Rev Med 46 223 234 1:CAS:528:DyaK2MXkvFSks7g%3D 10.1146/annurev.med.46.1.223 7598459
14. R Liddington Z Derewenda G Dodson D Harris 1988 Structure of the liganded T state of hemoglobin identifies the origin of cooperative oxygen binding Nature 331 725 728 1:CAS:528:DyaL1cXhs1emsr4%3D 10.1038/331725a0 3344047
15. 1c in diabetes mellitus N Eng J Med 295 417 420 10.1056/NEJM197608192950804
16. MF Perutz 1978 Hemoglobin structure and respiratoy transport Sci Am 239 92 125 1:CAS:528:DyaE1MXkvFOhsA%3D%3D 10.1038/scientificamerican1278-92 734439
17. PE James D Lang T Tufnell-Barret AB Milsom MP Frenneaux 2004 Vasorelaxation by red blood cells and impairment in diabetes: reduced nitric oxide and oxygen delivery by glycated hemoglobin Circ Res 94 976 983 1:CAS:528:DC%2BD2cXivVKqsro%3D 10.1161/01.RES.0000122044.21787.01 14963010
18. KH Gabbay JM Sosenko GA Banuchi MJ Mininsohn R Flückiger 1979 Glycosylated hemoglobins: increased glycosylation of hemoglobin A in diabetic patients Diabetes 28 337 340 1:CAS:528:DyaE1MXktFOrsbc%3D 10.2337/diabetes.28.4. 337 437373
19. LA Trivelli HM Ranney HT Lai 1971 Hemoglobin components in patients with diabetes mellitus N Engl J Med 284 353 357 1:CAS:528:DyaE3MXps1Ogug%3D%3D 10.1056/NEJM197102182840703 5539916
20. JM Drysdale P Righetti HF Bunn 1971 The separation of human and animal hemoglobins by isoelectric focusing in polyacrylamide gel Biochem Biophys Acta 229 42 50 1:CAS:528:DyaE3MXnt1Kisg%3D%3D 5543619
21. J Ambler B Janik G Walker 1983 Measurement of glyocosylated hemoglobin on cellulose acetate membranes by mobile affinity electrophoreses Clin Chem 29 340 343 1:CAS:528:DyaL3sXhtVersbY%3D 6821940
22. R Johnson P Metcalf J Baker 1982 Fructosamine: a new approach to the estimation of serum glycoproteins. An index of diabetic control Clin Chim Acta 127 87 95 10.1016/0009-8981(83)90078-5
23. JC Moore MC Outlaw AJ Barnes RC Turner 1986 Glycosylated plasma protein measurement by a semi-automated method Ann Clin Biochem 23 198 203 1:CAS:528:DyaL28XhvValu7o%3D 3767267
24. BH Wolffenbuttel D Giordano HW Founds R Bucala 1996 Long-term assessment of glucose control by haemoglobin-AGE measurement Lancet 347 513 515 1:STN:280:DyaK287nsVOisg%3D%3D 10.1016/S0140-6736(96)91141-1 8596270
25. M Roche P Rondeau NR Singh E Tarnus E Bourdon 2008 The antioxidant properties of serum albumin FEBS Lett 582 1783 1787 1:CAS:528: DC%2BD1cXms1Witrk%3D 10.1016/j.febslet.2008.04.057 18474236
26. N Iberg R Flückiger 1986 Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites J Biol Chem 261 13542 13545 1:CAS:528:DyaL28XlvVKhsL0%3D 3759977
27. R Bucala A Cerami 1992 Advanced glycosylation: chemistry, biology, and implications for diabetes and aging Adv Pharmacol 23 1 34 1:CAS:528: DyaK38Xks1Oms7o%3D 10.1016/S1054-3589(08)60961-8 1540533
28. AS Eble SR Thorpe JW Baynes 1983 Nonenzimatic glucosylation and glucose-dependent crosslinking of protein J Biol Chem 258 9406 9412 1:CAS:528:DyaL3sXkvVCjsrY%3D 6409904
29. KV Chace R Carubelli RE Nordquist 1991 The role of nonenzymatic glycosylation, transition metals, and free radicals in the formation of collagen aggregates Arch Biochem Biophys 288 473 480 1:CAS:528:DyaK3MXksVCmurw%3D 10.1016/0003-9861(91)90223-6 1898043
30. V Vishwanath KE Frank CA Elmets PJ Dauchot VM Monnier 1986 Glycation of skin collagen in type I diabetes mellitus, correlation with long-term complications Diabetes 35 916 921 1:STN:280:DyaL283nsFKmtQ%3D%3D 10.2337/diabetes.35.8.916 3732633
31. D Porte Jr MW Schwartz 1996 Diabetes complications: why is glucose potentially toxic? Science 272 699 700 1:CAS:528:DyaK28Xislamsbg%3D 10.1126/science.272.5262.699 8614830
32. LB Tijburg MJ Geelen LM van Golde 1998 Regulation of the biosynthesis of triacylglycerol, phosphatidylcholine and phosphatidylethanolamine in the liver Biochem Biophys Acta 1004 283 291
33. R Bucala Z Makita T Koschinsky A Cerami H Vlassara 1993 Lipid advanced glycosylation: pathway for lipid oxidation in vivo Proc Natl Acad Sci USA 90 6434 6438 1:CAS:528:DyaK3sXlsFOltrs%3D 10.1073/pnas.90.14.6434 8341651
34. M Aguilar-Hernández JD Méndez 2007 In vitro glycation of brain aminophospholipids by acetoacetate and its inhibition by urea Biomed Pharmacother 61 693 697 10.1016/j.biopha.2007.06.004 17640846
35. JP Segrest RL Jackson JD Morrisett AM Gotto Jr 1974 A molecular theory of lipid-protein interactions in the plasma lipoproteins FEBS Lett 38 247 258 1:CAS:528:DyaE2cXhsVajur0%3D 10.1016/0014-5793(74)80064-5 4368333
36. R Bucala Z Makita G Vega S Grundy T Koschinsky A Cerami H Vlassara 1994 Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency Proc Natl Acad Sci USA 91 9441 9445 1:CAS:528:DyaK2cXmt1Ort7Y%3D 10.1073/pnas.91.20.9441 7937786
37. G Virella SR Thorpe NL Alderson EM Stephan D Atchley F Wagner MF Lopes-Virella the DCCT/EDIC Research Group 2003 Autoimmune response to advanced glycosylation end-products of human LDL J Lipid Res 44 487 493 1:CAS:528:DC%2BD3sXitlCku74%3D 10.1194/jlr.M200370-JLR200 12562876
38. A Gugliucci M Bendayan 1995 Histones from diabetic rats contain increased levels of advanced glycation end products Biochem Biophys Res Commun 212 56 62 1:CAS:528:DyaK2MXmslemt7Y%3D 10.1006/bbrc.1995.1935 7612018
39. Y al-Abed E Schleicher W Voelter H Liebich A Papoulis R Bucala 1998 Identification of N2-(1-carboxymethyl)guanine (CMG) as a guanine advanced glycation end product Bioorg Med Chem Lett 8 2109 2110 1:CAS:528: DyaK1cXmtVKrtbg%3D 10.1016/S0960-894X(98)00398-9 9873495
40. A Takenaka S Fujita Y Sasada 1982 Interactions of nucleic-acid base-pairs with acidic side chains of protein. Crystal structures of adenine: 1-(2-carboxyethyl)uracil (1:1) complex and 1-methylcytosine: 9-(2-carboxyethyl)guanine (1:1) complex Nucleic Acids Symp Ser 11 281 284 1:CAS:528:DyaL3sXosFSjtQ%3D%3D 7183967
41. J Zurlo TJ Curphey R Hiley DS Longnecker 1982 Identification of 7-carboxymethylguanine in DNA from pancreatic acinar cells exposed to azaserine Cancer Res 42 1286 1288 1:CAS:528:DyaL38XhvFejsLs%3D 7060007
42. 2-(1-carboxyethyl)guanine (CEG) as a guanine advanced glycosylation endproduct Biochemistry 34 648 655 1:CAS:528:DyaK2MXivFOqsr8%3D 10.1021/bi00002a032 7819260
43. W Seidel M Pischetsrieder 1998 Reaction of guanosine with glucose under oxidative conditions Bioorg Med Chem Lett 8 2017 2022 1:CAS:528: DyaK1cXlsFCks7k%3D 10.1016/S0960-894X(98)00343-6 9873478
44. AT Lee A Plump C DeSimone A Cerami R Bucala 1995 A role for DNA mutations in diabetes-associated teratogenesis in transgenic embryos Diabetes 44 20 24 1:CAS:528:DyaK2MXivVyitLk%3D 10.2337/diabetes.44.1.20 7813809
45. AM Schmidt D Stern 2002 Atherosclerosis and diabetes: the RAGE connection Curr Atheroscler Rep 2 430 436 10.1007/s11883-000-0082-4
46. EA Friedman 1982 Diabetic nephropathy: strategies in prevention and management Kidney Int 21 730 738 10.1038/ki.1982.90
47. CE Mogensen 1984 Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes N Engl J Med 310 356 360 1:STN:280:DyaL2c%2FptlGjtA%3D%3D 10.1056/NEJM198402093100605 6690964
48. RH Noth AS Krolewski GA Kaysen TW Meyer M Schambelan 1989 Diabetic nephropathy: hemodynamic basis and implications for disease management Ann Intern Med 110 795 813 1:STN:280:DyaL1M3is1Ohtw%3D%3D 2653154
49. AR Andersen JS Christiansen JK Andersen S Kreiner T Deckert 1983 Diabetic nephropathy in type I (insulin-dependent) diabetes: an epidemiological study Diabetologia 25 496 501 1:STN:280:DyaL2c7gvFaqtA%3D%3D 10.1007/BF00284458 6363177
50. BA McVerry A Hopp C Fisher ER Huehns 1980 Production of pseudodiabetic renal glomerular changes in mice after repeated injections of glycosylated proteins Lancet 5 738 740 10.1016/S0140-6736(80)91234-9
51. M Sabbatini G Sansone F Uccello A Giliberti G Conte VE Andreucci 1992 Early glycosylation products induce glomerular hyperfiltration in normal rats Kidney Int 42 875 881 1:CAS:528:DyaK3sXhsVCqsLc%3D 10.1038/ki.1992.363 1453582
52. MP Cohen K Sharma Y Jin E Hud VY Wu J Tomaszewski FN Ziyadeh 1995 Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy J Clin Invest 95 2338 2345 1:CAS:528:DyaK2MXltlWrur0%3D 10.1172/JCI117926 7738197
53. B Sander M Larsen C Engler H Lund-Andersen HH Parving 1994 Early changes in diabetic retinopathy: capillary loss and blood-retina barrier permeability in relation to metabolic control Acta Ophthalmol (Copenh) 72 553 559 1:STN:280:DyaK2M7ptlGisg%3D%3D 10.1111/j.1755-3768.1994.tb07179.x
54. JC Mamputu G Renier 2002 Advanced glycation end products increase, through a protein kinase C-dependent pathway, vascular endothelial growth factor expression in retinal endothelial cells. Inhibitory effect of glicazide J Diabetes Complications 16 284 293 10.1016/S1056-8727(01)00229-X 12126787
55. HF Bunn PJ Higgins 1981 Reaction of monosaccharides with proteins: possible evolutionary significance Science 213 222 224 1:CAS:528: DyaL3MXksFKrtr8%3D 10.1126/science.12192669 12192669
56. MS Swamy A Abraham EC Abraham 1992 Glycation of human lens proteins: preferential glycation of alpha A subunits Exp Eye Res 54 337 345 1:CAS:528:DyaK38Xitleisrk%3D 10.1016/0014-4835(92)90046-U 1521566
57. N Araki N Ueno B Chakrabarti Y Morino S Horiuchi 1992 Immunochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging J Biol Chem 267 10211 10214 1:CAS:528:DyaK38XktVCrtLs%3D 1587810
58. Z Kyselova M Stefek V Bauer 2004 Pharmacological prevention of diabetic cataract J Diabetes Complications 18 129 140 1:STN:280:DC%2BD2c3itlShtg%3D%3D 10.1016/S1056-8727(03)00009-6 15120709
59. S Watkinson R Seewoodhary 2008 Ocular complications associated with diabetes mellitus Nurs Stand 22 51 57 1:STN:280:DC%2BD1c3ks1Gitw%3D%3D 18405017
60. AI Vinik TS Park KB Stansberry GL Pittenger 2004 Diabetic neuropathies Diabetologia 43 957 973 10.1007/s001250051477
61. PJ Thornalley 2002 Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options Int Rev Neurobiol 50 37 57 1:CAS:528:DC%2BD38XotFaqur8%3D 10.1016/S0074-7742(02)50072-6 12198817
62. SK Williams NL Howarth JJ Devenny MW Bitensky 1982 Structural and functional consequences of increased tubulin glycosylation in diabetes mellitus Proc Natl Acad Sci USA 79 6546 6550 1:CAS:528:DyaL38XmtFektLg%3D 10.1073/pnas.79.21.6546 6959136
63. NA Cullum J Mahon K Stringer WG McLean 1991 Glycation of rat sciatic nerve tubulin in experimental diabetes mellitus Diabetologia 34 387 389 1:CAS:528:DyaK3MXltlehs70%3D 10.1007/BF00403175 1715829
64. H Vlassara M Brownlee A Cerami 1983 Excessive nonenzymatic glycosylation of peripheral and central nervous system myelin components in diabetic rats Diabetes 32 670 674 1:CAS:528:DyaL3sXltlOksr0%3D 10.2337/diabetes.32.7.670 6862112
65. H Vlassara M Brownlee A Cerami 1984 Accumulation of diabetic rat peripheral nerve myelin by macrophages increases with the presence of advanced glycosylation endproducts J Exp Med 160 197 207 1:CAS:528:DyaL2cXkslSns78%3D 10.1084/jem.160.1.197 6736870
66. M Peppa J Uribarri H Vlassara 2004 The role of advanced glycation end products in the development of atherosclerosis Curr Diab Rep 4 31 36 10.1007/s11892-004-0008-6 14764277
67. K Pyorala M Laakso M Uusitupa 1987 Diabetes and atherosclerosis: an epidemiologic view Diabetes Metab Rev 3 463 524 1:STN:280:DyaL2s7ovFKitg%3D%3D 10.1002/dmr.5610030206 3552530
68. JV Glenn AW Stitt 2009 The role of advanced glycation end products in retinal ageing and disease Biochim Biophys Acta 1790 1109 1116 1:CAS:528:DC%2BD1MXhtFamsr3O 19409449
69. M Brownlee H Vlassara A Cerami 1984 Nonenzymatic glycosylation and the pathogenesis of diabetic complications Ann Intern Med 101 527 537 1:CAS:528:DyaL2cXmtVygtbs%3D 6383165
70. HF Bunn KH Gabbay PM Gallop 1978 The glycosylation of hemoglobin: relevance to diabetes mellitus Science 200 21 27 1:CAS:528:DyaE1cXhvVOht7w%3D 10.1126/science.635569 635569
71. KH Gabbay 1976 Editorial: Glycosylated hemoglobin and diabetic control N Eng J Med 295 443 444 1:STN:280:DyaE283itVegsw%3D%3D 10.1056/NEJM197608192950810
72. MJ McDonald R Shapiro M Bleichman J Solway HF Bunn 1978 Glycosylated minor components of human adult hemoglobin J Biol Chem 253 2327 2332 1:CAS:528:DyaE1cXhs1Gksbo%3D 632272
73. NB Ruderman JR Williamson M Brownlee 1992 Glucose and diabetic vascular disease FASEB J 6 2905 2914 1:CAS:528:DyaK38Xls1ymurk%3D 1644256
74. SK Jain R McVie J Duett JJ Herbst 1989 Erithrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes Diabetes 38 1539 1543 1:CAS:528:DyaK3cXltlWrug%3D%3D 10.2337/diabetes.38.12.1539 2583378
75. YM Li AX Tan H Vlassara 1995 Antibacterial activity of lysozyme and lactoferrin is inhibited by binding of advanced glycation-modified proteins to a conserved motif Nat Med 10 1057 1061 10.1038/nm1095-1057
76. JL Wautier RC Paton MP Wautier D Pintigny E Abadie P Passa JP Caen 1981 Increased adhesion of erythrocytes to endothelial cells in diabetes mellitus and their relation to the vascular complications N Engl J Med 305 237 242 1:STN:280:DyaL3M3itVymsw%3D%3D 10.1056/NEJM198107303050501 7242613
77. M Brownlee A Cerami 1981 The biochemistry of the complications of diabetes mellitus Ann Rev Biochem 50 385 432 1:CAS:528:DyaL3MXkvFCqsr0%3D 10.1146/annurev.bi.50.070181.002125 6168237
78. 2-microglobulin and modification with advanced glycation end products J Chromatogr B Biomed Sci Appl 758 109 115 1:CAS:528: DC%2BD3MXjvV2msbo%3D 10.1016/S0378-4347(01)00139-6 11482729
79. MM Newkirk K LePage T Niwa L Rubin 1998 Advanced glycation endproducts (AGE) on IgG, a target for circulating antibodies in North American Indians with rheumatoid arthritis (RA) Cell Mol Biol 44 1129 1138 1:CAS:528: DyaK1cXns1Sks7c%3D 9846895